Sennosides 25 by Elysium Pharmaceuticals Ltd Sennosides

Sennosides 25 by

Drug Labeling and Warnings

Sennosides 25 by is a Otc medication manufactured, distributed, or labeled by Elysium Pharmaceuticals Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SENNOSIDES 25- sennosides tablets 25 tablet 
Elysium Pharmaceuticals Ltd

----------

Sennosides

Laxative

Calcium sennosides 20% IH, Colloidal Silicon Di oxide USP/NF, Croscarmellose sodium USP/NF, Crospovidone [Kollidon] USP/NF, Dicalcium phosphate/ dibasic calcium phosphate [DIREC] USP/NF, Filmcoat AMB-51D0393632-Blue lake IH, Magnesium stearate. USP/NF, Microcrystalline cellulose (PH-102) USP/NF, Sodium lauryl sulfate USP/NF, Stearic acid powder USP/NF, Purified water

Sennosides Tablets USP, 25 mg Label

Label

SENNOSIDES 25 
sennosides tablets 25 tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 14803-165
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNA ALATA LEAF (UNII: 4BXR6YZN92) (SENNA ALATA LEAF - UNII:4BXR6YZN92) SENNA ALATA LEAF25 mg
Inactive Ingredients
Ingredient NameStrength
MAGNESIUM STEARATE (UNII: 70097M6I30)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
PARAFFINUM LIQUIDUM (UNII: T5L8T28FGP)  
CALCIUM PHOSPHATE (UNII: 97Z1WI3NDX)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
POLYVINYL ALCOHOL (UNII: 532B59J990)  
Product Characteristics
ColorblueScoreno score
ShapeROUNDSize11mm
FlavorImprint Code S3
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 14803-165-0040000 in 1 BOX; Type 0: Not a Combination Product01/13/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00701/13/2021
Labeler - Elysium Pharmaceuticals Ltd (915664486)
Establishment
NameAddressID/FEIBusiness Operations
Elysium Pharmaceuticals Ltd915664486manufacture(14803-165) , analysis(14803-165)

Revised: 2/2026
Document Id: 4a3b1b61-e2f6-9231-e063-6394a90a74b4
Set id: 4026e3db-169b-64dc-e063-6294a90a86cc
Version: 9
Effective Time: 20260207